Docket for 18-817
|
| Oct 26 2018 | Application (18A461) to extend the time to file a petition for a writ of certiorari from November 12, 2018 to December 27, 2018, submitted to The Chief Justice. | | Main DocumentLower Court Orders/OpinionsProof of Service | | Oct 31 2018 | Application (18A461) granted by The Chief Justice extending the time to file until December 27, 2018. | | | | Dec 27 2018 | Petition for a writ of certiorari filed. (Response due January 28, 2019) | | PetitionAppendixCertificate of Word CountProof of Service | | Jan 22 2019 | Motion to extend the time to file a response from January 28, 2019 to February 12, 2019, submitted to The Clerk. | | Main Document | | Jan 23 2019 | Motion to extend the time to file a response is granted and the time is extended to and including February 12, 2019. | | | | Jan 28 2019 | Brief amici curiae of Intellectual Property and Innovation Professors, Engine Advocacy, et al. filed. | | Main DocumentCertificate of Word CountProof of Service | | Jan 28 2019 | Brief amici curiae of The Association for Accessible Medicines and Certain Individual Companies filed. | | Main DocumentCertificate of Word CountProof of Service | | Feb 12 2019 | Brief of respondent Vanda Pharmaceuticals USA, Inc. in opposition filed. | | Main DocumentCertificate of Word CountProof of Service | | Feb 26 2019 | Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. | | Main DocumentProof of ServiceOther | | Feb 27 2019 | DISTRIBUTED for Conference of 3/15/2019. | | | | Mar 15 2019 | Letter of Hikma Pharmaceuticals USA Inc., et al. received. | | Main DocumentProof of Service | | Mar 18 2019 | The Solicitor General is invited to file a brief in this case expressing the views of the United States. | | | | May 22 2019 | Amendment to Rule 29.6 Corporate Disclosure Statement filed with respect to brief in opposition of respondent Vanda Pharmaceuticals Inc. | | Main Document | | Dec 06 2019 | Brief amicus curiae of United States filed. | | Proof of ServiceMain Document | | Dec 20 2019 | Supplemental brief of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. | | Main DocumentCertificate of Word CountProof of Service | | Dec 23 2019 | DISTRIBUTED for Conference of 1/10/2020. | | | | Dec 23 2019 | Supplemental brief of respondent Vanda Pharmaceuticals USA, Inc. filed. (Distributed) | | Main DocumentCertificate of Word CountProof of Service | | Dec 26 2019 | Letter of December 26, 2019 from counsel for petitioner received. (Distributed) | | Main Document | | Jan 13 2020 | Petition DENIED. | | |
|